CD30 positive systemic anaplastic large cell lymphoma program in Pharmaceutical Benefits Scheme (PBS) 012-18051139

Background
Process
Resources
Training & Support

CD30 positive systemic anaplastic large cell lymphoma restriction and item codes

Do not share this attachment externally. See Freedom of Information - Information Publication Scheme.
$\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.png$ CD30 positive systemic anaplastic large cell lymphoma (sALCL) restriction and item codes

Contact details

PBS Complex Drugs Programs team

Forms

CD30 positive systemic anaplastic large cell lymphoma - brentuximab vedotin - initial authority application (PB123)

Services Australia website

Lymphoma - systemic anaplastic large cell lymphoma

External websites